PROGESTAGENS AND HIGH-DENSITY LIPOPROTEINS

This publication has 10 references indexed in Scilit:

• High Density Lipoprotein Subfractions during Oral and Cutaneous Administration of 17β-Estradiol to Menopausal Women*
  Journal of Clinical Endocrinology & Metabolism, 1983
• Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: Differential changes in high-density lipoprotein subclasses
  American Journal of Obstetrics and Gynecology, 1983
• High Density Lipoprotein-2 and Hepatic Lipase: Reciprocal Changes Produced by Estrogen and Norgestrel*
  Journal of Clinical Endocrinology & Metabolism, 1982
• Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers
  Contraception, 1982
• Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins
  Contraception, 1982
• Different effects of two progestins on plasma high density lipoprotein (HDL2) and postheparin plasma hepatic lipase activity
  Atherosclerosis, 1981
• Reduction of plasma high-density lipoprotein2 cholesterol and increase of postheparin plasma hepatic lipase activity during progestin treatment
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1981
• Lipoprotein Changes May Be Minimized by Proper Composition of a Combined Oral Contraceptive
  Fertility and Sterility, 1981
• Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.
  BMJ, 1980
• Effect of Oxandrolone Treatment on the Activity of Lipoprotein Lipase, Hepatic Lipase and Phospholipase a₁of Human Postheparin Plasma
  New England Journal of Medicine, 1975